These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 36362141)
21. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors. Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963 [TBL] [Abstract][Full Text] [Related]
22. Expression of epithelial-mesenchymal transition and cancer stem cell markers in colorectal adenocarcinoma: Clinicopathological significance. Choi JE; Bae JS; Kang MJ; Chung MJ; Jang KY; Park HS; Moon WS Oncol Rep; 2017 Sep; 38(3):1695-1705. PubMed ID: 28677737 [TBL] [Abstract][Full Text] [Related]
23. Profilin 2 promotes migration, invasion, and stemness of HT29 human colorectal cancer stem cells. Kim MJ; Lee YS; Han GY; Lee HN; Ahn C; Kim CW Biosci Biotechnol Biochem; 2015; 79(9):1438-46. PubMed ID: 25964982 [TBL] [Abstract][Full Text] [Related]
24. Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness. Siemens H; Jackstadt R; Kaller M; Hermeking H Oncotarget; 2013 Sep; 4(9):1399-415. PubMed ID: 24009080 [TBL] [Abstract][Full Text] [Related]
25. Zerumbone inhibits epithelial-mesenchymal transition and cancer stem cells properties by inhibiting the β-catenin pathway through miR-200c. Dermani FK; Amini R; Saidijam M; Pourjafar M; Saki S; Najafi R J Cell Physiol; 2018 Dec; 233(12):9538-9547. PubMed ID: 29943808 [TBL] [Abstract][Full Text] [Related]
26. [Inhibition of GAS5 promoted invasion, migration and epithelial-mesenchymal transition of colorectal cancer cells via miR-21/PTEN/Akt axis]. Xiong BH; Li SS; Ren ZY; Zhang Z; Liu YZ; Sun Y; Chi JL; Luo HY Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1168-1174. PubMed ID: 36380665 [No Abstract] [Full Text] [Related]
27. Inhibition of pancreatic cancer stem cell characteristics by α-Mangostin: Molecular mechanisms involving Sonic hedgehog and Nanog. Ma Y; Yu W; Shrivastava A; Srivastava RK; Shankar S J Cell Mol Med; 2019 Apr; 23(4):2719-2730. PubMed ID: 30712329 [TBL] [Abstract][Full Text] [Related]
28. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer. Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356 [TBL] [Abstract][Full Text] [Related]
29. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis. Hur K; Toiyama Y; Takahashi M; Balaguer F; Nagasaka T; Koike J; Hemmi H; Koi M; Boland CR; Goel A Gut; 2013 Sep; 62(9):1315-26. PubMed ID: 22735571 [TBL] [Abstract][Full Text] [Related]
30. Bufalin Inhibits Cellular Proliferation and Cancer Stem Cell-Like Phenotypes via Upregulation of MiR-203 in Glioma. Liu T; Wu C; Weng G; Zhao Z; He X; Fu C; Sui Z; Huang SX Cell Physiol Biochem; 2017; 44(2):671-681. PubMed ID: 29169175 [TBL] [Abstract][Full Text] [Related]
31. Wild-type p53 suppresses the epithelial-mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR‑145. Ren D; Wang M; Guo W; Zhao X; Tu X; Huang S; Zou X; Peng X Int J Oncol; 2013 Apr; 42(4):1473-81. PubMed ID: 23404342 [TBL] [Abstract][Full Text] [Related]
32. Induction of the Epithelial-to-Mesenchymal Transition of Human Colorectal Cancer by Human TNF-β (Lymphotoxin) and its Reversal by Resveratrol. Buhrmann C; Yazdi M; Popper B; Kunnumakkara AB; Aggarwal BB; Shakibaei M Nutrients; 2019 Mar; 11(3):. PubMed ID: 30917533 [TBL] [Abstract][Full Text] [Related]
33. Effects of the CRYAB gene on stem cell-like properties of colorectal cancer and its mechanism. Dai A; Guo X; Yang X; Li M; Fu Y; Sun Q J Cancer Res Ther; 2022 Sep; 18(5):1328-1337. PubMed ID: 36204880 [TBL] [Abstract][Full Text] [Related]
34. MiR-3622a-3p acts as a tumor suppressor in colorectal cancer by reducing stemness features and EMT through targeting spalt-like transcription factor 4. Chang S; Sun G; Zhang D; Li Q; Qian H Cell Death Dis; 2020 Jul; 11(7):592. PubMed ID: 32719361 [TBL] [Abstract][Full Text] [Related]
35. Claudin-7 deficiency promotes stemness properties in colorectal cancer through Sox9-mediated Wnt/β-catenin signalling. Xu C; Ding YH; Wang K; Hao M; Li H; Ding L J Transl Med; 2021 Jul; 19(1):311. PubMed ID: 34281572 [TBL] [Abstract][Full Text] [Related]
36. Incomplete cellular reprogramming of colorectal cancer cells elicits an epithelial/mesenchymal hybrid phenotype. Hiew MSY; Cheng HP; Huang CJ; Chong KY; Cheong SK; Choo KB; Kamarul T J Biomed Sci; 2018 Jul; 25(1):57. PubMed ID: 30025541 [TBL] [Abstract][Full Text] [Related]
37. MiRNA-206 suppresses PGE2-induced colorectal cancer cell proliferation, migration, and invasion by targetting TM4SF1. Park YR; Seo SY; Kim SL; Zhu SM; Chun S; Oh JM; Lee MR; Kim SH; Kim IH; Lee SO; Lee ST; Kim SW Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30135139 [TBL] [Abstract][Full Text] [Related]
38. Reversal of epithelial-mesenchymal transition and inhibition of tumor stemness of breast cancer cells through advanced combined chemotherapy. Cui Y; Zhao M; Yang Y; Xu R; Tong L; Liang J; Zhang X; Sun Y; Fan Y Acta Biomater; 2022 Oct; 152():380-392. PubMed ID: 36028199 [TBL] [Abstract][Full Text] [Related]
39. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis. Yu CC; Chen PN; Peng CY; Yu CH; Chou MY Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999 [TBL] [Abstract][Full Text] [Related]
40. Knocking down LSD1 inhibits the stemness features of colorectal cancer stem cells. Chen J; Zhao J; Ding J; Wang Z; Du J; Wu C Braz J Med Biol Res; 2020; 53(7):e9230. PubMed ID: 32520208 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]